Max Healthcare Institute Ltd Stock Price Today (NSE: MAXHEALTH)
Fundamental Score
Max Healthcare Institute Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Max Healthcare Institute Ltd share price today is ₹1076.15, up +0.00% on NSE/BSE as of 17 February 2026. Max Healthcare Institute Ltd (MAXHEALTH) is a Large-cap company in the Hospital sector with a market capitalisation of ₹1.09L (Cr). The 52-week high for MAXHEALTH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 77.65x, MAXHEALTH is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 12.72% and a debt-to-equity ratio of 0.33.
Max Healthcare Institute Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Max Healthcare Institute Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Max Healthcare Institute Share Price: A ROCE Efficiency Analysis
A key trend in the hospital industry is the increasing focus on operational efficiency to drive profitability amidst rising healthcare costs. This analysis examines the "Max Healthcare Institute share price" (₹1039.849976) through the lens of its Return on Capital Employed (ROCE), a crucial indicator of how effectively the company generates profits from its invested capital. With a Price-to-Earnings (PE) ratio of 77.65 and a ROCE of 14.88%, Max Healthcare presents an interesting case for investors seeking value in the healthcare sector.
The 14.88% ROCE suggests that Max Healthcare is generating a reasonable return on its investments. However, interpreting this figure requires careful comparison with industry peers. While detailed ROCE data for peers like Strategic Minerals Plc and Abateas Industries Ltd. is unavailable, a relative assessment focusing on qualitative factors is possible. For example, considering
Nephro Care India Limited, an investor might compare the quality of management teams. If Max Healthcare's management is perceived as significantly superior in efficiently deploying capital and navigating the complexities of the healthcare landscape, then its 14.88% ROCE might be viewed more favorably, even if Nephro Care India Limited exhibits a seemingly higher ROCE based on limited data (hypothetically speaking).ROCE is a critical component of a company's economic moat, or its ability to defend its competitive advantages. A consistently high ROCE implies that Max Healthcare can reinvest its earnings at attractive rates of return, further strengthening its position within the market. A lower ROCE, conversely, could suggest challenges in deploying capital efficiently, potentially eroding its competitive edge over time. The 14.88% ROCE, therefore, needs to be considered in conjunction with other factors such as market share, brand reputation, and the regulatory environment to fully assess the sustainability of Max Healthcare's profitability.
This financial analysis of Max Healthcare Institute Ltd. is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. The information presented is observational and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Max Healthcare Institute Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MAXHEALTH across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Operating Margins (25.31%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (74.34%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (25.07%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (46.01% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (60.31% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (80.50% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (8.54x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹1988.23 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 71.83%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 77.65x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Low Promoter Commitment (23.74%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Max Healthcare Institute Ltd Financial Statements
Comprehensive financial data for Max Healthcare Institute Ltd including income statement, balance sheet and cash flow
About MAXHEALTH (Max Healthcare Institute Ltd)
Max Healthcare Institute Ltd (MAXHEALTH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹1.09L (Cr). Max Healthcare Institute Ltd has delivered a Return on Equity (ROE) of 12.72% and a ROCE of 14.88%. The debt-to-equity ratio stands at 0.33, reflecting the company's capital structure. Investors tracking MAXHEALTH share price can monitor key metrics including P/E ratio, promoter holding of 23.74%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
MAXHEALTH Share Price: Frequently Asked Questions
What is the current share price of Max Healthcare Institute Ltd (MAXHEALTH)?
As of 17 Feb 2026, 10:15 am IST, Max Healthcare Institute Ltd share price is ₹1076.15. The MAXHEALTH stock has a market capitalisation of ₹1.09L (Cr) on NSE/BSE.
Is MAXHEALTH share price Overvalued or Undervalued?
MAXHEALTH share price is currently trading at a P/E ratio of 77.65x, compared to the industry average of 52.84x. Based on this relative valuation, the Max Healthcare Institute Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of MAXHEALTH share price?
The 52-week high of MAXHEALTH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Max Healthcare Institute Ltd share price?
Key factors influencing MAXHEALTH share price include quarterly earnings growth (Sales Growth: 25.07%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Max Healthcare Institute Ltd a good stock for long-term investment?
Max Healthcare Institute Ltd shows a 5-year Profit Growth of 80.50% and an ROE of 12.72%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.33 before investing in MAXHEALTH shares.
How does Max Healthcare Institute Ltd compare with its industry peers?
Max Healthcare Institute Ltd competes with major peers in the Hospital. Investors should compare MAXHEALTH share price P/E of 77.65x and ROE of 12.72% against the industry averages to determine competitive standing.
What is the P/E ratio of MAXHEALTH and what does it mean?
MAXHEALTH share price has a P/E ratio of 77.65x compared to the industry average of 52.84x. Investors pay ₹78 for every ₹1 of annual earnings.
How is MAXHEALTH performing according to Bull Run's analysis?
MAXHEALTH has a Bull Run fundamental score of 69.1/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MAXHEALTH belong to?
MAXHEALTH operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Max Healthcare Institute Ltd share price.
What is Return on Equity (ROE) and why is it important for MAXHEALTH?
MAXHEALTH has an ROE of 12.72%, which shows decent profitability but room for improvement. ROE measures how efficiently Max Healthcare Institute Ltd generates profits from shareholders capital.
How is MAXHEALTH debt-to-equity ratio and what does it indicate?
MAXHEALTH has a debt-to-equity ratio of 0.33, which indicates moderate leverage that should be monitored.
What is MAXHEALTH dividend yield and is it a good dividend stock?
MAXHEALTH offers a dividend yield of 0.13%, meaning you receive ₹0.13 annual dividend for every ₹100 invested in Max Healthcare Institute Ltd shares.
How has MAXHEALTH share price grown over the past 5 years?
MAXHEALTH has achieved 5-year growth rates of: Sales Growth 46.01%, Profit Growth 80.50%, and EPS Growth 60.31%.
What is the promoter holding in MAXHEALTH and why does it matter?
Promoters hold 23.74% of MAXHEALTH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Max Healthcare Institute Ltd.
What is MAXHEALTH market capitalisation category?
MAXHEALTH has a market capitalisation of ₹109416 crores, placing it in the Large-cap category.
How volatile is MAXHEALTH stock?
MAXHEALTH has a beta of N/A. A beta > 1 suggests the Max Healthcare Institute Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MAXHEALTH operating profit margin trend?
MAXHEALTH has a 5-year average Operating Profit Margin (OPM) of 25.31%, indicating the company's operational efficiency.
How is MAXHEALTH quarterly performance?
Recent quarterly performance shows Max Healthcare Institute Ltd YoY Sales Growth of 25.07% and YoY Profit Growth of 74.34%.
What is the institutional holding pattern in MAXHEALTH?
MAXHEALTH has FII holding of 51.80% and DII holding of 20.03%. Significant institutional holding often suggests professional confidence in the Max Healthcare Institute Ltd stock.